SPDR® S&P Biotech ETF (XBI)

During the Trading Day
222.06 +4.26 / +1.96%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
225.07 +3.01 / +1.36%
Volume: 1.2K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+10.72% 3 years+42.20%
3 months+21.74% 5 years+29.92%
1 year+34.61% Since inception+18.11%
Data through 03/03/2015

Quote Details

Previous close$217.80
Open day’s range215.14 – 223.56
Net asset value (NAV)217.70 (03/02/2015)
Daily volume1,011,358
Average volume (3 months)691,331
Data as of 3:59pm ET, 03/04/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+29.92%+22.29%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.171.47
Net assets$1.8B$1.6B
Average market cap$2.2B$35.3B
Average P/E--26.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
FMI Foundation Medicine Inc2.23%
HALO Halozyme Therapeutics Inc1.97%
NBIX Neurocrine Biosciences Inc1.68%
OPK OPKO Health Inc1.63%
ICPT Intercept Pharmaceuticals Inc1.61%
-- 1.61%
RARE Ultragenyx Pharmaceutical Inc1.54%
NVAX Novavax Inc1.49%
EXEL Exelixis Inc1.47%
ALKS Alkermes Plc1.46%

To view my watchlist

Not a member yet?

Sign up now for a free account